Reminder: Invitation to Roche ’s First Quarter Sales 2024 Presentation

 Roche will publish its Sales Results for the 1st Quarter 2024 prior to the opening of the Swiss Stock Exchange onWednesday, 24 April 2024. 07:00 CEST / 06:00BST / 01:00 AM EDT / 10:00 PM PDT (evening before)Release will be e-mailed and posted on the Roche IR website>click herePresentation slides will be posted on the Roche IR website>click here 14:00 – 15:30 CEST / 13:00 – 14:30 BST08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDTThe webinar will start with presentations by senior management, followed by a Q&A session.Presenters:Thomas Schinecker, CEO Roche GroupAlan Hippe, Chief Financial and IT Officer RocheTeresa Graham, CEO Roche PharmaceuticalsMatt Sause, CEO Roche Diagnostics   We would like to invite all interested parties to participate in the webinar and to pre-register for the eventhere.*Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail]. A replay of the webcast will be available via>ir.roche.com*privacy notice Best regards,  Bruno EschliHead of Investor Relations  Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. Sabine Borngr äberPhone: [phone]e-mail:[e-mail] Dr. Birgit MasjostPhone: [phone]e-mail:[e-mail]    Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail] 

Source: Roche Investor Update - April 17, 2024 Category: Pharmaceuticals Source Type: news